Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
14.1M
-
Shares change
-
+191K
-
Total reported value, excl. options
-
$83.8M
-
Value change
-
+$1.18M
-
Number of buys
-
10
-
Number of sells
-
-11
-
Price
-
$5.96
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q1 2016
30 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q1 2016.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.1M shares
.
Largest 10 shareholders include NEA Management Company, LLC (8.58M shares), WELLINGTON MANAGEMENT GROUP LLP (2.67M shares), FRANKLIN RESOURCES INC (1.01M shares), SPHERA FUNDS MANAGEMENT LTD. (338K shares), Cormorant Asset Management, LLC (284K shares), VANGUARD GROUP INC (235K shares), Candriam Luxembourg S.C.A. (210K shares), WALL STREET ASSOCIATES (150K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (110K shares), and DEUTSCHE BANK AG\ (106K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.